Racial differences in medication use among older, long-stay Veterans Affairs Nursing Home Care Unit patients

Consultant Pharmacist

Volumn 24, Issue 6, 2009, Pages 439-446

  Hanlon, Joseph T ^a,b,c   Wang, Xiaoqiang ^d   Good, C Bernie ^a,d,e   Rossi, Michelle I ^a,b,f   Stone, Roslyn A ^d,f   Semla, Todd P ^g,h   Cunningham, Francesca E ^a,i   Handler, Steven M ^a,d  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

^c Center for Health Equity Research   (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

^e Veterans Affairs Center for Medication Safety   (United States)

^f UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^g Veterans Affairs Pharmacy Benefits Management   (United States)

^h NORTHWESTERN UNIVERSITY   (United States)

ⁱ Pharmacoepidemiologic Research   (United States)

Author keywords

Aged; Drug utilization; Nursing home; Race

Indexed keywords

ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; ANTIHISTAMINIC AGENT; ANTIINFECTIVE AGENT; ANXIOLYTIC AGENT; CENTRAL NERVOUS SYSTEM AGENTS; ELECTROLYTE; HORMONE; NEUROLEPTIC AGENT; NOOTROPIC AGENT; OPIATE; SEROTONIN UPTAKE INHIBITOR; VITAMIN;

AGED; ALLERGY; ARTICLE; CHI SQUARE TEST; COGNITIVE DEFECT; CONTROLLED STUDY; DEPRESSION; DRUG USE; DRUG UTILIZATION; EDUCATIONAL STATUS; ENDOCRINE DISEASE; FEMALE; HEART DISEASE; HUMAN; LONGITUDINAL STUDY; MALE; MENTAL DISEASE; NURSING HOME; NURSING HOME PATIENT; PAIN; POLYPHARMACY; PREVALENCE; RACE DIFFERENCE; RESPIRATORY TRACT DISEASE; VETERAN;

AFRICAN CONTINENTAL ANCESTRY GROUP; AGED; AGED, 80 AND OVER; DRUG UTILIZATION; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; NURSING HOMES; PHARMACEUTICAL PREPARATIONS; POLYPHARMACY; UNITED STATES; UNITED STATES DEPARTMENT OF VETERANS AFFAIRS; VETERANS;

EID: 67649488316     PISSN: 08885109     EISSN: None     Source Type: Journal    
DOI: 10.4140/TCP.n.2009.050     Document Type: Article

References (33)

1. Hume AL, Lapane, KL Middleton S et al. SAGE database: medication use in elderly nursing facility residents. Consult Pharm 1998;13:1356-1364
2. Doshi JA, Shaffer T, Briesacher BA. National estimates of medication use in nursing homes: findings from the 1997 Medicare Current Beneficiary Survey and the 1996 Medical Expenditure survey. J Am Geriatr Soc 2005;53:438-443
3. Tobias DE, Sey M. General and psychotherapeutic medication use in 328 nursing facilities: a year 2000 national survey. Consult Pharm 2001;16:54-64.
4. Institute of Medicine. Unequal Treatment: Confronting Racial and Ethnic Disparities in Health Care. Washington, DC: National Academy Press; 2002.
5. American College of Physicians. Racial and ethnic disparities in health care. Ann Intern Med 2004;141:221-225
6. Agency for Healthcare Research and Quality. US National Healdi Care Disparities Report, 2004.
7. Fillenbaum GG, Hanlon JT. Racial and ethnic disparities in medication utilization in older adults. Am J Geriatr Pharmacother 2006;4:93-96 (Pubitemid 44057813)
8. Smith DB, Feng Z, Fennel ML et al. Separate and unequal: racial segregation and disparities in quality across US nursing homes. Health Affairs 2007;26:1448-1458
9. Brown MN, Lapane KL, Luisi AF. The management of depression in older nursing home residents. J Am Geriatr Soc 2002;50:69-76. (Pubitemid 34053025)
10. Allswordi JE, Toppa R, Palin NC et al. Racial and ethnic disparities in the pharmacologic management of diabetes mellitus among long-term care facility residents. Ethn Dis 2005;15:205-212 (Pubitemid 40561638)
11. Christian JB, Lapane KL, Toppa R. Racial disparities in receipt of secondary stroke prevention agents among US nursing home residents. Stroke 2003;34:2693-2697 (Pubitemid 37392769)
12. Kilbourne AM, Switzer G, Hyman K et al. Advancing healdi disparities research within the health care system: a conceptual framework. Am J Public Health 2006;96:2113-2121 (Pubitemid 44865101)
13. Saha S, Freeman M, Toure J et al. Racial and ethnic disparities in the VA health care system: a systematic review. J Gen Intern Med 2008;23:654-671
14. Minimum Data Set (MDS) Version 2.0. http://www.cms.hhs.gov/ NursingHomeQualityInits. Accessed November 1, 2008.
15. Mor V. A comprehensive clinical assessment tool to inform policy and practice: applications of the Minimum Data Set. Med Care 2004;42 Suppl 4:111-50-111-159
16. Burrows AB, Morris JN, Simon SE et al. Development of a minimum data set-based depression rating scale for use in nursing homes. Age Ageing 2000;29:165-172 (Pubitemid 30193154)
17. Hartmaier SL, Sloane PD, Guess HA et al. Validation of the Minimum Data Set Cognitive Performance Scale: agreement with the Mini-Mental State Examination. J Gerontol 1995;50:128-133
18. McConnell ES, Pieper CF, Sloane RJ et al. Effects of cognitive performance on change in physical function in long-stay nursing home residents. J Gerontol 2002;57:778-784 (Pubitemid 35470953)
19. National Formulary, VA Pharmacy Benefits Management Services. http://www.pbm.va.gov/natform/vaclass.xls. Accessed November 1, 2008.
20. Rosner B. Fundamentals of Biostatistics. 6th ed. Stamford, CT: Thomson Learning; 2006.
21. Blazer D, Hybels C, Simonsik E et al. Marked differences in antidepressant use by race in an elderly community sample: 1986-1996. Am J Psych 2000;157:1089-1094 (Pubitemid 30432489)
22. Zisselman MH, Smith RV, Smith SA et al. Racial and socioeconomic differences in psychiatric symptoms in nursing home residents: a Minimum Data Set-based pilot study. J Am Med Dir Assoc 2006;7:17-22. (Pubitemid 43224337)
23. Thakur M, Blazer DG. Depression in long term care. J Am Med Dir Assoc 2008;9:82-87
24. Llewellyn-Jones RH, Snowdon J. Depression in nursing homes: ensuring adequate treatment. CNS Drugs 2007;21:627-640 (Pubitemid 47121790)
25. Lehman JM, Blaiss MS. Selecting the optimal oral antihistamine for patients with allergic rhinitis. Drugs 2006;66:2309-2319 (Pubitemid 46072444)
26. Agostini JV, Leo-Summers LS, Inouye SK. Cognitive and other adverse effects of diphenhydramine use in hospitalized older patients. Arch Intern Med 2001;161:2091-2097 (Pubitemid 36231503)
27. Fick DM, Cooper JW, Wade WE et al. Updating the Beers criteria for potentially inappropriate medication use in older adults: results of a US consensus panel of experts. Arch Intern Med 2003;163:2716-2724 (Pubitemid 37517412)
28. Hartikainen SA, Lonnroos E, Louhivuori K. Medication as a risk factor for falls: critical systematic review. J Gerontol 2007;62A:1172-1181 (Pubitemid 47599431)
29. Simons KJ, Watson WT, Martin TJ et al. Diphenhydramine: pharmacokinetics and pharmacodynamics in elderly adults, young adults, and children. J Clin Pharmacol 1990;30:665-671 (Pubitemid 20241475)
30. Glass JR, Sproule BA, Herrmann N et al. Effects of 2-week treatment with temazepam and diphenhydramine in elderly insomniacs: a randomized, placebo-controlled trial. J Clin Psychopharmacol 2008;28:182-188
31. Chen I, Kurz J, Pasanen M et al. Racial differences in opioid use for chronic nonmalignant pain. J Gen Intern Med 2005;20:593-598 (Pubitemid 41026242)
32. Bernabei R, Gambassi G, Lapane K et al. Management of pain in elderly patients with cancer. SAGE Study Group: systematic assessment of geriatric drug use via epidemiology. JAMA 1998;279:1877-1882 (Pubitemid 28299283)
33. Won AB, Lapane KL, Vallow S et al. Persistent nonmalignant pain and analgesic prescribing patterns in elderly nursing home residents. J Am Geriat Soc 2004;52:867-874 (Pubitemid 38789056)